Background Cognitive impairment is a common nonmotor manifestation of Parkinson's
disease, with deficits ranging from mild cognitive difficulties in 1 or more of the cognitive …

The aim of the present systematic review was to examine the evidence on the accuracy and
psychometric properties of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) for …

Objective In this study, we assessed plasma biomarkers to identify cognitive impairment in
Parkinson's disease (PD) patients by applying ultra-sensitive immunomagnetic reduction …

Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by
the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative - IOS Press You are viewing a javascript …

Objectives: The feasibility and safety of the use of neurorehabilitation technology
(SMARTfit® Trainer system) by physical therapists in implementing a gamified physical …

Background. An increased prevalence of Parkinson's disease (PD) disease has been
previously reported in subjects with Fabry disease (FD) carrying alpha‐galactosidase (GLA) …

When discussing disease states both in clinical and research contexts, objective
quantification of symptoms is important to assess disease severity, progression, and …

Abstract The Parkinson's Disease-Cognitive Rating Scale (PD-CRS) is a cognitive screening
battery that includes subtests to assess cortical and subcortical functions. It is a valid …

Objectives Parkinson's disease is the second most prevalent progressive
neurodegenerative disease and causes considerable disability in patients. We conducted a …

Purpose To investigate the reliability and validity of Parkinson's Disease-Cognitive Rating
Scale (PD-CRS) in Iranian patients with idiopathic PD. Methods One hundred and eighty …